South Africa laid out a long-awaited plan to distribute Covid-19 vaccines, saying it will cost R20.6 billion to inoculate two thirds of the population and the state will be the sole purchaser. The government will agree contracts with suppliers and allocate vaccines to regional authorities and the private sector, Health Minister Zweli Mkhize said in a presentation to Parliament on Thursday. The majority of the doses will come from AstraZeneca Plc, which has set a price of R54 each compared with Moderna Inc’s R536, he said. Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership. Read: SA medical schemes to fund Covid-19 vaccines Mkhize said he expects to start obtaining vaccines next month and inoculate 67% of the population by the end of the year. The plan comes as the government faces mounting criticism over its lack of progress in procuring vaccines, with no supply deals signed with pharmaceutical companies even as several other countries start their programs. Mkhize is speaking the day after South Africa reported a daily record of confirmed cases, and President Cyril Ramaphosa and other top officials are considering strengthening lockdown measures. The government has said previously it expects to begin receiving shots in the second quarter of 2021 to cover a 10th of its about 60 million people through the Covax initiative, which is trying to ensure equitable access to vaccines. © 2021 Bloomberg L.P.